Stub batch r15b — open questions

• Did the FB-401 (Roseomonas mucosa) RCT report results separately for the 2–5-year-olds it enrolled, and did that subgroup differ from adults?
• Is there any safe doxycycline course length for skin disease (e.g. perioral dermatitis, MRSA) in children under 8, given AAP/CDC support for ≤21-day courses?
• Has SAHPRA issued a call-up notice covering topical herbal/complementary “eczema” creams, and are any registered with an eczema indication for children?